Literature DB >> 20802235

TrkC plays an essential role in breast tumor growth and metastasis.

Wook Jin1, Gyoung Mi Kim, Min Soo Kim, Mi Hee Lim, Chohee Yun, Joon Jeong, Jeong-Seok Nam, Seong-Jin Kim.   

Abstract

Tropomyosin-related kinase (Trk) C, a member of the Trk family of neurotrophin receptors, has been implicated in the growth and survival of human cancer tissues. Here, we report that TrkC is frequently overexpressed in human breast cancers and plays an essential role in tumor growth and metastasis. Ectopic expression of TrkC in non-malignant mammary epithelial cells suppressed anoikis, which correlated with activation of the Ras-mitogen-activated protein kinase and phosphatidylinositol-3-OH kinase (PI3K)/Akt pathways, and reduced expression of the metastatic regulator Twist. Furthermore, suppression of TrkC expression in highly metastatic mammary carcinoma cells inhibited their growth in vitro, as well as their ability to metastasize from the mammary gland to the lung in vivo. These results have identified TrkC as a critical regulator of breast cancer cell growth and metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20802235     DOI: 10.1093/carcin/bgq180

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  37 in total

1.  TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.

Authors:  Jamie L Croucher; Radhika Iyer; Nanxin Li; Valentina Molteni; Jon Loren; W Perry Gordon; Tove Tuntland; Bo Liu; Garrett M Brodeur
Journal:  Cancer Chemother Pharmacol       Date:  2014-11-14       Impact factor: 3.333

2.  Methylation and expression patterns of tropomyosin-related kinase genes in different grades of glioma.

Authors:  Mahalakshmi Palani; R Arunkumar; Arrambakam Janardhanam Vanisree
Journal:  Neuromolecular Med       Date:  2014-05-20       Impact factor: 3.843

3.  A zwitterionic near-infrared dye linked TrkC targeting agent for imaging metastatic breast cancer.

Authors:  Zhen Yang; Syed Muhammad Usama; Feng Li; Kevin Burgess; Zheng Li
Journal:  Medchemcomm       Date:  2018-08-03       Impact factor: 3.597

4.  TrkC promotes survival and growth of leukemia cells through Akt-mTOR-dependent up-regulation of PLK-1 and Twist-1.

Authors:  Min Soo Kim; Gyoung Mi Kim; Yun-Jeong Choi; Hye Joung Kim; Yoo-Jin Kim; Wook Jin
Journal:  Mol Cells       Date:  2013-07-04       Impact factor: 5.034

5.  Small Molecule Ligands For Active Targeting Of TrkC-expressing Tumor Cells.

Authors:  Eunhwa Ko; Anyanee Kamkaew; Kevin Burgess
Journal:  ACS Med Chem Lett       Date:  2012-10-09       Impact factor: 4.345

6.  A novel microRNA located in the TrkC gene regulates the Wnt signaling pathway and is differentially expressed in colorectal cancer specimens.

Authors:  Sadat Dokanehiifard; Atena Yasari; Hadi Najafi; Meisam Jafarzadeh; Maryam Nikkhah; Seyed Javad Mowla; Bahram M Soltani
Journal:  J Biol Chem       Date:  2017-01-18       Impact factor: 5.157

7.  TrkC expression predicts favorable clinical outcome in invasive ductal carcinoma of breast independent of NT-3 expression.

Authors:  Wei Zhang; Zhi-Chun Lin; Tong-Xian Zhang; Shan Liu; Xia Liu; Jun-Jun Liu; Yun Niu
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

8.  TrkC-Targeted Kinase Inhibitors And PROTACs.

Authors:  Bosheng Zhao; Kevin Burgess
Journal:  Mol Pharm       Date:  2019-09-12       Impact factor: 4.939

9.  Copy number analysis of ductal carcinoma in situ with and without recurrence.

Authors:  Kylie L Gorringe; Sally M Hunter; Jia-Min Pang; Ken Opeskin; Prue Hill; Simone M Rowley; David Y H Choong; Ella R Thompson; Alexander Dobrovic; Stephen B Fox; G Bruce Mann; Ian G Campbell
Journal:  Mod Pathol       Date:  2015-06-19       Impact factor: 7.842

10.  Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model.

Authors:  Radhika Iyer; Lea Wehrmann; Rebecca L Golden; Koumudi Naraparaju; Jamie L Croucher; Suzanne P MacFarland; Peng Guan; Venkatadri Kolla; Ge Wei; Nicholas Cam; Gang Li; Zachary Hornby; Garrett M Brodeur
Journal:  Cancer Lett       Date:  2016-01-18       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.